AbCellera Biologics Inc.
US ˙ NasdaqGS ˙ CA00288U1066

SecurityABCL / AbCellera Biologics Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
D. E. Shaw & Co., Inc. ownership in ABCL / AbCellera Biologics Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 0 shares of AbCellera Biologics Inc. (US:ABCL) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 77,776 shares of AbCellera Biologics Inc.. The current value of the position is $0 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (ABCL) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ABCL / AbCellera Biologics Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 0 -100.00 0
2026-02-17 2025-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 77,776 1,293 1.69 266 -30.99 0.0001
2025-11-14 2025-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 76,483 25,409 49.75 385 119.43 0.0002
2025-08-14 2025-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 51,074 51,074 175 0.0001
2025-02-14 2024-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 0 -420,240 -100.00 0 -100.00
2024-11-14 2024-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 420,240 -46,325 -9.93 1,093 -20.93 0.0009
2024-08-14 2024-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 466,565 13,330 2.94 1,381 -32.73 0.0013
2024-05-15 2024-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 453,235 422,602 1,379.56 2,053 1,079.89 0.0018
2024-02-14 2023-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 30,633 -404,720 -92.96 175 -91.31 0.0002
2023-11-14 2023-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 435,353 -77,450 -15.10 2,003 -39.55 0.0021
2023-08-14 2023-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 512,803 -955,593 -65.08 3,313 -70.08 0.0034
2023-05-15 2023-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 1,468,396 -979,008 -40.00 11,072 -55.34 0.0119
2023-02-14 2022-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 2,447,404 -327,955 -11.82 24,792 -9.68 0.0274
2022-11-14 2022-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 2,775,359 1,672,839 151.73 27,448 133.76 0.0328
2022-08-15 2022-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 1,102,520 1,073,423 3,689.12 11,742 4,034.51 0.0138
2022-05-16 2022-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 29,097 -37,014 -55.99 284 -69.95 0.0003
2022-02-14 2021-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 66,111 40,418 157.31 945 83.50 0.0008
2021-11-15 2021-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 25,693 25,693 515 0.0005
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-05-16 2022-03-31 13F ABCELLERA BIOLOGICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F ABCELLERA BIOLOGICS COM Put 224,600 0.00 3,212 -28.64 n/a n/a n/a
2021-11-15 2021-09-30 13F ABCELLERA BIOLOGICS COM Put 224,600 4,501 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.